Health News

Report: Remdesivir in a few days, “EU could get” approval for Corona treatment

The originally for the treatment of Ebola developed drug Remdesivir could get a media report says that soon a marketing authorisation in the EU. The Swedish TV channel TV4 reported, citing the head of the Department for infectious diseases at the Swedish medicines Agency.

The decision on whether the drug a patient receives an approval for the treatment of Corona in the EU, could fall, therefore, already “in a few days”. In the United States Remdesivir has already received a special permit for the treatment of Corona patients.

Read more about Coronavirus in the News-Ticker of FOCUS Online.

In Germany, the Federal Institute for drugs and medical devices (BfArM) has a hardness at the beginning of April, a so-called drug program for Remdesivir confirmed. Thus, in this country Doctors to their patients the active ingredient to be administered. In addition, the BfArM has approved, according to information currently, a total of four clinical trials with Remdesivir for the treatment of Covid-19.

More children to intensive care unit: infections in Lodge explains why this is not a reason to worry

FOCUS Online More children to intensive care unit: infection Loge explains why there is no reason for concern